Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
about
Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein familyTissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's diseaseTissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectinNeural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challengesBeyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1Deimination of human filaggrin-2 promotes its proteolysis by calpain 1Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's diseaseIdentification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenaseCellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic miceIntracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.Molecular cloning and characterization of a hemolymph clottable protein from tiger shrimp (Penaeus monodon).Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeatsDevelopmental expression of DAX1 in the European sea bass, Dicentrarchus labrax: lack of evidence for sexual dimorphism during sex differentiationMethod for screening and MALDI-TOF MS sequencing of encoded combinatorial libraries.Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansionProtein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations.The pathogenesis of Machado Joseph Disease: a high manganese/low magnesium initiated CAG expansion mutation in susceptible genotypes?Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamineMutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease.Inability of keratinocytes lacking their specific transglutaminase to form cross-linked envelopes: absence of envelopes as a simple diagnostic test for lamellar ichthyosisNeurodegenerative diseases and transglutaminase.Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.Trinucleotide repeats and neuropsychiatric disorders.Therapeutics development for triplet repeat expansion diseases.Molecular cloning and characterization of amh and dax1 genes and their expression during sex inversion in rice-field eel Monopterus albus.Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregatesTransglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological lengthAggregation of expanded huntingtin in the brains of patients with Huntington disease.Transglutaminase activation in neurodegenerative diseases.Transglutaminases and neurodegeneration.Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease geneEngineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteinsRole of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases.Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.
P2860
Q24318288-D06A471B-492E-4222-BEBA-9145354CDCA8Q24618141-80761155-47CD-4259-883A-BE78B9089C2EQ24680821-9A462753-6DA7-4D87-ADAF-6724934D9B55Q26775932-645D2ADD-36B8-4D0C-A704-C3E27CA0ECE6Q27008548-2A503F6E-5DE5-48B0-89DA-5522218FAD81Q28118423-4998B67D-5F97-4CE7-B0BF-F3B6636EC5B0Q28118540-370259A4-D372-452F-A403-B072109206F8Q28366199-2F254CB5-9993-4395-86B1-8F27278C2964Q28510296-89DDEAD8-3B7C-47A8-AC05-76FEEA676FD0Q30441983-93E6D9C8-A8BE-4B10-9B6D-11ACEC31A088Q30812901-9234B4C9-C7D5-43AC-B9CF-4C96A9359505Q31122113-AD9D2BF8-270D-43BF-905D-0B07F23F8331Q33286204-28B7FC0A-9A9E-4DB3-9FEF-09541A95E640Q33294891-D943362C-45D8-4020-9BB4-0DC2004BCE74Q33536410-448B5454-C77A-4ADD-A9AA-5CC0845E232DQ33788913-A7A3DFC7-B4E1-43A5-ABEA-2177971CD83EQ33926887-D056D759-2393-44F8-BE37-39F5B6C22483Q34081469-A2D2B97C-8564-42EA-ADE5-2ED91C14428BQ34382416-68C8D29D-E7BA-4312-8E02-08B14A539930Q34805750-0E622797-FEE0-4CCF-ACE5-B7759A27DBE4Q34829422-63D573AA-37D4-4845-8FED-6BBDF9918361Q35742561-641DADB5-62AE-476E-B7D0-3977B007CFB0Q36250381-940292F8-92CC-40B8-B468-735ACCC7F184Q36255989-AABAEC0B-98D4-4021-93BF-F704C159219DQ36265488-F93BF0D8-97FB-4FDE-BA5C-406FD87A48C4Q36277195-33A2C739-620B-48F1-A0F9-DE47D86F7280Q36291277-96A0FF4E-5F51-4BE2-883E-F1A6C2FC42C5Q36342395-09B33959-E5FE-4B72-9CD7-6548C5614C98Q36826440-BB1C0552-1FD3-45D2-A9D6-4EDE31043F7EQ37079417-8129E558-AF08-4F91-93C0-F87759C1A9D8Q37352964-6D919905-0F0D-4307-AF76-553D957B82A2Q37365083-E63E8249-C794-4518-89C6-6571AB736E5FQ37432151-3C823E41-40AB-4E9B-B437-3B1C6A0958CBQ37961564-85BBE05D-A8F5-41CE-B8D1-99E9E9E6E6B5Q38857583-712AC10D-B7F9-4742-A1F3-2CEECFC02966Q39697142-8D729789-5DB5-49A7-894B-3ED99978DCFCQ40164617-12BBEDA8-B72F-40B0-AC88-48DB72840237Q40457537-CD6B4D3F-1A6B-4D60-9B0E-0610BC07C811Q40556729-D0E09701-272C-4EAC-8456-1F6C61876ED4Q40725013-3A08B999-B51E-4ADC-94AA-1C91DFDC453E
P2860
Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptides containing glutamine ...... iseases of the nervous system.
@en
Peptides containing glutamine ...... iseases of the nervous system.
@nl
type
label
Peptides containing glutamine ...... iseases of the nervous system.
@en
Peptides containing glutamine ...... iseases of the nervous system.
@nl
prefLabel
Peptides containing glutamine ...... iseases of the nervous system.
@en
Peptides containing glutamine ...... iseases of the nervous system.
@nl
P2093
P2860
P356
P1476
Peptides containing glutamine ...... iseases of the nervous system.
@en
P2093
P2860
P304
14580-14585
P356
10.1073/PNAS.93.25.14580
P407
P577
1996-12-01T00:00:00Z